Pascal Soriot is the CEO of AstraZeneca. Soriot is based in the United Kingdom. Soriot was born in 1959 in France and educated at École nationale vétérinaire d'Alfort and HEC Paris.
Recent developments
AI summary of recent coverageRecent coverage has focused on the collapse of AstraZeneca's proposed $400 billion merger with Bristol Myers, which prompted commentary on Soriot's strategic decision-making and the rationale behind abandoning the large-scale deal. Beyond the failed acquisition, coverage has also highlighted Soriot's efforts to address trial risks through artificial intelligence deployment, the company's major investment plans in China, and warnings about regulatory pressures in markets like Germany.
Summarized from the headlines below; see each source for the full story.
Key Facts
Source: Wikidata ↗- Born
- May 23, 1959 · France
- Citizenship
- France
- Education
- École nationale vétérinaire d'Alfort, HEC Paris
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on Pascal Soriot, it will appear here — and tie into the news timeline.
In the News
12 stories- Financial Times·
How AstraZeneca’s $400bn tie-up with US rival Bristol Myers unravelled
- The Guardian·
Soriot should explain the curious case of AstraZeneca’s non-deal
- The Times·
Why AstraZeneca boss is right to be paranoid about its success
- Reuters·
Breakingviews - AstraZeneca US M&A idea would ail more than cure
- FirstWord Pharma·
Spotlight On: Will mega-M&A come full circle to further define Pascal Soriot's AstraZeneca?
- BioSpace·
AstraZeneca has no plans to ramp up dealmaking in wake of Wainua failure
- Endpoints News·
AstraZeneca looks to AI to ease risk in late-stage trials, speed up filings
- CNBC·
AstraZeneca CEO Pascal Soriot goes one-on-one with Jim Cramer
- Yahoo Finance·
AstraZeneca Pascal Soriot Delivers Remarks as Firm Celebrates Transfer to NYSE
- Fierce Pharma·
AstraZeneca CEO's conservative MFN model excludes reference markets from forecast
- NAVLIN DAILY·
AstraZeneca CEO Warns of German Drug Launch Freeze Amid GKV Savings Plan
- astrazeneca.com·
AstraZeneca plans to invest $15 billion in China through 2030 to pioneer the next-generation of innovative medicines
Pascal Soriot: FAQ
- What company does Pascal Soriot lead?
- Pascal Soriot is CEO of AstraZeneca.
- Where was Pascal Soriot educated?
- Pascal Soriot studied at École nationale vétérinaire d'Alfort, HEC Paris.